Our Impact
Investing in transformative, not incremental, innovation

Products

Omega Funds portfolio products since inception, with >$1m cost. Past performance is not indicative of future returns.

View Complete Portfolio List

Ampyra

Extended release, oral ion-channel blocker to improve walking in Multiple Sclerosis patients.

Ampyra

Andrew

The liquid handling robot designed to enhance the reproducibility and efficiency of the pipetting process.

Andrew

Andrew+

The second generation liquid handling robot, can perform a wide range of complex experimental steps.

Andrew+

Arymo ER

Opioid agonist for the management of severe pain.

Arymo ER

Axiron

Topical testosterone for treating males with low or no testosterone.

Axiron

Baxdela

Antibiotic to treat acute bacterial skin and skin structure infections in both IV and oral formulation.

Baxdela

Baxfendy

Baxfendy (baxdrostat) is a first-in-class, prescription medication approved for adults with uncontrolled or resistant hypertension.

Baxfendy

BiDil

Indicated for use with other heart medicines to treat heart failure in African American patients.

BiDil

Blincyto

First bi-specific antibody for the treatment of acute lymphoblastic leukemia.

Blincyto

Breyanzi

Breyanzi: Gene therapy (CAR-T) treatment for certain types of non-Hodgkin lymphoma.

Breyanzi

CryoConsole

Cardiac Cryoablation System for treating paroxysmal atrial fibrillation.

CryoConsole

Cultivance

Weed control solution containing genetically modified soybean plants and tailor made herbicides.

Cultivance

Encelto

Cell therapy for idiopathic macular telangiectasia type 2 (MacTel), a degenerative eye disease, according to Neurotech Pharmaceuticals and the FDA.

Encelto

Enerzair Breezhaler

The first-in-class LABA/LAMA/ICS fixed-dose combination for patients whose asthma is uncontrolled with LABA/ICS.

Enerzair Breezhaler

Epi ProColon

The first blood test for colorectal cancer screening.

Epi ProColon

Epi ProLung

Assay for detection of mSHOX2 in patients suspected of having lung cancer.

Epi ProLung

EvaMist

Estradiol transdermal spray for the treatment of vasomotor symptoms (hot flashes) associated with menopause.

EvaMist

Evrenzo

First-in-class, oral drug for the treatment of anemia in chronic kidney disease patients on dialysis.

Evrenzo

Firazyr

Injectable bradykinin receptor antagonist for the treatment of acute hereditary angioedema.

Firazyr

Generic Lovenox

Enoxaparin sodium: low molecular-weight heparin to prevent and treat deep vein thrombosis.

Generic Lovenox

Glatopa

The first FDA-approved, substitutable generic version of Copaxone, a treatment for relapsing forms of multiple sclerosis.

Glatopa

Heplisav-B

The first new hepatitis B vaccine in the United States in more than 25 years and the only two-dose hepatitis B vaccine for adults.

Heplisav-B

Ibtrozi

Targeted therapy medication used to treat adults with advanced ROS1-positive non-small cell lung cancer (NSCLC).

Ibtrozi

Imlygic

The first oncolytic viral therapy for the local treatment of recurrent melanoma.

Imlygic

Kimmtrak

The first and only therapy for the treatment of unresectable or metastatic uveal melanoma to be approved by the FDA.

Kimmtrak

Lyxumia

Subcutaneously administered GLP-1 agonist for type 2 diabetes.

Lyxumia

MagnetOs

Indicated for use as an osteoconductive and osteoinductive bone void filler in the skeletal system.

MagnetOs

Mammaprint

A diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize.

Mammaprint

Mavyret

Pan-genotypic treatment for hepatitis C patients without cirrhosis and who are new to treatment.

Mavyret

Mint

Mint is an FDA-cleared, tubeless insulin patch pump designed with a two-piece reusable and disposable architecture to deliver automated insulin therapy for people managing diabetes.

Mint

Neuroseal

A synthetic tissue sealant candidate for the prevention of CSF leakage following cranial or spinal surgery.

Neuroseal

Nevisense

The world’s first objective diagnostic support tool for non-visual detection of malignant melanoma.

Nevisense

NorLevo

The first emergency contraceptive pill available in Japan.

NorLevo

Nuzyra

The first once-daily antibiotic to treat CABP and ABSSSI in IV and oral formulations.

Nuzyra

One-Lab

Cloud-based intelligent laboratory software to design and execute liquid handling protocols.

One-Lab

OpenArray

High-throughput system for PCR-based genotyping, gene expression, and microRNA analysis.

OpenArray

Pipette+

The first connected smart pipetting system for maximum experiment repeatability with the minimum of effort.

Pipette+

Rezzayo

First new treatment option approved for patients with candidemia and invasive candidiasis in over a decade.

Rezzayo

Rivfloza

A novel monthly injection for a rare genetic condition characterized by recurrent kidney and bladder stones that can lead to progressive kidney damage.

Rivfloza

Seebri Breezhaler

Once-daily LAMA bronchodilator for maintenance treatment to relieve symptoms in adult patients with COPD.

Seebri Breezhaler

Seebri Neohaler

Twice-daily LAMA bronchodilator for long-term maintenance treatment of airflow obstruction in patients with COPD.

Seebri Neohaler

Selincro

An oral opioid receptor ligand for treating alcohol dependence.

Selincro

Seysara

Tetracycline-derived antibiotic for the treatment of moderate to severe acne vulgaris.

Seysara

Sophion Qube

A high throughput system for ion channel screening.

Sophion Qube

SpineJet

Hydrosurgery system for minimally invasive spine surgery.

SpineJet

TenJet

Hydrosurgery system for minimally invasive needling, debridement and lavage of diseased tendon tissue

TenJet

Trilogy

The Trilogy THV System is the first and only transcatheter heart valve in the United States indicated for native, symptomatic, severe aortic regurgitation in patients who are judged by a Heart Team to be at high or greater risk for surgical aortic valve replacement.

Trilogy

Tudriqev

Tudriqev is a genetically modified oncolytic viral therapy for the treatment of advanced, refractory melanoma.

Tudriqev

Ultibro Breezhaler

Once-daily fixed dose combination of long-acting LABA/LAMA for maintenance treatment of COPD.

Ultibro Breezhaler

Utibron Neohaler

Twice-daily fixed dose combination of long-acting LABA/LAMA for long-term maintenance treatment of COPD.

Utibron Neohaler

Viekira Pak

Extended-release tablets for treating chronic hepatitis C virus infection.

Viekira Pak

Xadago

Used with levodopa to control motor fluctuations in Parkinson’s disease patients.

Xadago

Xenazine

Indicated for treating chorea associated with Huntington’s disease.

Xenazine

Xenleta

First IV and oral antibiotic with a novel mechanism of action approved by the FDA in nearly two decades.

Xenleta

Zemdri

An antibiotic indicated for the treatment of complicated urinary tract infections (cUTI), including pyelonephrit

Zemdri

Zoryve

First and only topical PDE4 inhibitor approved for the treatment of plaque psoriasis, including intertriginous psoriasis

Zoryve

Our ImpactInvesting in transformative, not incremental, innovation

Products

Our Impact
Investing in transformative, not incremental, innovation